Microablative Fractional CO<sub>2</sub> Laser Improves Dyspareunia Related to Vulvovaginal Atrophy: A Pilot Study
Stefano Salvatore(Vita-Salute San Raffaele University), Nicola Zerbinati(University of Insubria), Simone Ferrero(Ospedale Policlinico San Martino), Massimo Candiani(San Raffaele University of Rome), Lavinia Quaranta(Vita-Salute San Raffaele University), Umberto Leone Roberti Maggiore(Fondazione IRCCS Istituto Nazionale dei Tumori), Ilaria Baini(Vita-Salute San Raffaele University), Alice Cola(University of Milano-Bicocca), Filomena Giulia Sileo(Vita-Salute San Raffaele University), Marta Parma(Vita-Salute San Raffaele University), Massimo Origoni(Vita-Salute San Raffaele University)
Cited by 53
Related Papers
ESHRE guideline: endometriosis
|Human Reproduction Open|2022|1.5k
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
|The Lancet Public Health|2022|350
A 12-week treatment with fractional CO<sub>2</sub>laser for vulvovaginal atrophy: a pilot study
|Climacteric|2014|302
Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment
|Lasers in Medical Science|2014|265
Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue
|Menopause The Journal of The North American Menopause Society|2015|241